| Mr Mukesh J Jhaveri, MD | |
|
24 Grove St, Middletown, NY 10940-4806 | |
| (845) 343-4677 | |
| (845) 343-5249 |
| Full Name | Mr Mukesh J Jhaveri |
|---|---|
| Gender | Male |
| Speciality | Neuropsychiatry |
| Experience | 51 Years |
| Location | 24 Grove St, Middletown, New York |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1275526709 | NPI | - | NPPES |
| 00716129 | Medicaid | NY | |
| 0622508 | Medicaid | NJ |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2084P0800X | Psychiatry & Neurology - Psychiatry | 139330 (New York) | Secondary |
| 2084N0400X | Psychiatry & Neurology - Neurology | 139330 (New York) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Garnet Health Medical Center | Middletown, NY | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Middletown Medical Pc | 2567464308 | 141 |
News Archive
According to to figures from the NHS Litigation Authority, the NHS has paid out over £112m since 2005 in compensation because doctors have failed to spot or prevent fatal blood clots.
Spark Therapeutics, a late-stage gene therapy company developing treatments for debilitating genetic diseases, announced today that it has entered into a global collaboration with Pfizer Inc. for the development and potential commercialization of SPK-FIX, a development program advancing proprietary, bio-engineered adeno-associated virus (AAV) vectors for the potential treatment of hemophilia B.
"The public would be better served if policymakers left their desks in Washington and met with us in our homes, where every day is a struggle."
Rhythm Pharmaceuticals, a biotechnology company developing peptide therapeutics for metabolic diseases, announced today that it has completed the first close on its Series A equity financing of $21 million. The financing was led by MPM Capital and New Enterprise Associates. The funds will be used to develop products licensed from Ipsen.
OptiMedica Corp., a global ophthalmic device company, has released new details regarding the development of its proprietary femtosecond laser system for cataract surgery. The new system, which combines OptiMedica's breakthrough pattern scanning technology, an ultra-fast laser and integrated Optical Coherence Tomography imaging, is designed to dramatically improve the complex cataract procedure by replacing its most technically demanding and manual steps.
› Verified 6 days ago
| Entity Name | Middletown Medical Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1902855828 PECOS PAC ID: 2567464308 Enrollment ID: O20070208000144 |
News Archive
According to to figures from the NHS Litigation Authority, the NHS has paid out over £112m since 2005 in compensation because doctors have failed to spot or prevent fatal blood clots.
Spark Therapeutics, a late-stage gene therapy company developing treatments for debilitating genetic diseases, announced today that it has entered into a global collaboration with Pfizer Inc. for the development and potential commercialization of SPK-FIX, a development program advancing proprietary, bio-engineered adeno-associated virus (AAV) vectors for the potential treatment of hemophilia B.
"The public would be better served if policymakers left their desks in Washington and met with us in our homes, where every day is a struggle."
Rhythm Pharmaceuticals, a biotechnology company developing peptide therapeutics for metabolic diseases, announced today that it has completed the first close on its Series A equity financing of $21 million. The financing was led by MPM Capital and New Enterprise Associates. The funds will be used to develop products licensed from Ipsen.
OptiMedica Corp., a global ophthalmic device company, has released new details regarding the development of its proprietary femtosecond laser system for cataract surgery. The new system, which combines OptiMedica's breakthrough pattern scanning technology, an ultra-fast laser and integrated Optical Coherence Tomography imaging, is designed to dramatically improve the complex cataract procedure by replacing its most technically demanding and manual steps.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Mr Mukesh J Jhaveri, MD 111 Maltese Dr, Middletown, NY 10940-2141 Ph: (845) 342-4774 | Mr Mukesh J Jhaveri, MD 24 Grove St, Middletown, NY 10940-4806 Ph: (845) 343-4677 |
News Archive
According to to figures from the NHS Litigation Authority, the NHS has paid out over £112m since 2005 in compensation because doctors have failed to spot or prevent fatal blood clots.
Spark Therapeutics, a late-stage gene therapy company developing treatments for debilitating genetic diseases, announced today that it has entered into a global collaboration with Pfizer Inc. for the development and potential commercialization of SPK-FIX, a development program advancing proprietary, bio-engineered adeno-associated virus (AAV) vectors for the potential treatment of hemophilia B.
"The public would be better served if policymakers left their desks in Washington and met with us in our homes, where every day is a struggle."
Rhythm Pharmaceuticals, a biotechnology company developing peptide therapeutics for metabolic diseases, announced today that it has completed the first close on its Series A equity financing of $21 million. The financing was led by MPM Capital and New Enterprise Associates. The funds will be used to develop products licensed from Ipsen.
OptiMedica Corp., a global ophthalmic device company, has released new details regarding the development of its proprietary femtosecond laser system for cataract surgery. The new system, which combines OptiMedica's breakthrough pattern scanning technology, an ultra-fast laser and integrated Optical Coherence Tomography imaging, is designed to dramatically improve the complex cataract procedure by replacing its most technically demanding and manual steps.
› Verified 6 days ago
Kavneet Kaur, M.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: Garnet Health Doctors, Pc, 707 E Main St, Middletown, NY 10940 Phone: 845-333-7575 Fax: 845-333-7201 | |
Dr. Parukutty M Krishnan, M.D Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 45 Ashley Ave, Middletown, NY 10940 Phone: 845-326-8074 Fax: 845-326-8003 | |
Dr. Lisa Ann Batson, M.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 155 Crystal Run Rd, Middletown, NY 10941 Phone: 845-703-6999 Fax: 845-703-6297 | |
Dr. Manouchehr Lavian, MD LLC Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 129 Wickham Ave, Middletown, NY 10940 Phone: 845-341-1805 Fax: 845-342-9218 | |
Dr. Joanne Tortomas Brodkin White, M.D. Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 45 Ashley Ave, Middletown, NY 10940 Phone: 845-326-8074 | |
Dr. Romi Shah, M.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 75 Crystal Run Rd Ste 135, Middletown, NY 10941 Phone: 845-333-7800 | |
Howard Lam, MD Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 45 Ashley Ave, Middletown, NY 10940 Phone: 845-326-8027 |